Лучшие больницы для «Breast Reduction Surgery» в Дели (NCR), Индия

Macromastia — pathologically enlarged breasts — is a recognised medical condition that imposes multisystem physiological burden. Mechanically, the excess weight (which can range from 500 g to more than 2,000 g of tissue per breast) creates a chronic forward-flexion load on the cervical and thoracic spine, contributing to trapezius myofascial pain, interscapular nerve entrapment, cervicogenic headaches, and accelerated degenerative disc disease. Dermatologically, chronic skin-on-skin maceration beneath the inframammary fold produces recurrent intertrigo, candidal infections, and contact dermatitis. Respiratorily, large ptotic breasts restrict thoracic excursion, worsening obstructive sleep apnoea and exercise-induced dyspnoea. Psychosocially, macromastia is strongly linked to body-image disorder, social anxiety, and clinical depression, all quantifiable through validated instruments such as the BREAST-Q and the Multidimensional Body-Self Relations Questionnaire (MBSRQ).

• Women aged 18 and above (skeletal maturity confirmed) with disproportionately large breasts causing documented functional symptoms (neck/back/shoulder pain, skin rashes, postural deformity, activity limitation)
• Patients with a minimum resection volume typically ≥ 500 g per breast (threshold used by most insurance and surgical panels)
• Body Mass Index (BMI) ideally ≤ 35 kg/m²; patients with BMI 35–40 may be considered after optimisation; BMI > 40 is a relative contraindication requiring prehabilitation
• Non-smokers, or patients who have ceased smoking ≥ 6 weeks preoperatively (smoking raises wound-healing complication risk by 3–5× in skin-flap surgery)
• Patients with stable weight (not planning significant further weight loss or pregnancy in the near term, as these events alter outcomes)
• +1 more

Required Preoperative Diagnostics:

• Full-field digital mammography (FFDM) or breast ultrasound for women ≥ 35 years or with a first-degree family history of breast cancer
• MRI breast if inconclusive mammographic findings or BRCA carrier status
• Complete blood count (CBC), coagulation profile (PT/INR/aPTT), metabolic panel, HbA1c (for diabetic patients)
• Electrocardiogram (ECG) and anaesthesia fitness evaluation
• Thrombosis risk stratification using the Caprini Score (DVT prophylaxis planning)
• +1 more

Breast reduction surgery is not a single monolithic operation; the surgeon selects a technique based on breast volume, degree of ptosis (Regnault classification Grades I–III), desired final volume, NAC position, patient body habitus, and the critical need to preserve nipple-areola vascularity and sensory innervation.

1. Inferior Pedicle with Inverted-T (Wise Pattern) Technique — Gold Standard for Large Reductions The most widely performed approach globally, suitable for large to massive macromastia. The NAC is carried on a broad inferior dermoglandular pedicle supplied by the fourth intercostal perforator and the internal mammary artery branches. Resection volumes of 500 g to > 2,500 g per side are reliably achieved. The resultant scar pattern forms an anchor or inverted-T (periareolar + vertical + horizontal inframammary). Long-term outcome data spanning > 30 years confirm durable relief of functional symptoms in > 95% of patients.

2. Vertical (Short-Scar / Lejour / Hall-Findlay) Technique — Preferred for Moderate Macromastia The vertical technique eliminates the horizontal inframammary scar, leaving only a periareolar + vertical scar (lollipop pattern). The superomedial pedicle, popularised by Hall-Findlay, provides excellent NAC perfusion and superior long-term breast shape. Optimal for resection volumes of 300–800 g per breast. Associated with lower revision rates for scar-related complaints and superior patient satisfaction on BREAST-Q aesthetics subscale in randomised trials.

3. Superomedial Pedicle with Wise Pattern — Versatile Hybrid Combines the reliable perfusion of the superomedial pedicle with the skin-pattern versatility of the Wise pattern. Increasingly preferred by high-volume surgeons for moderate-to-large reductions requiring precise NAC repositioning > 10 cm.

PRE-OPERATIVE PHASE (4–6 Weeks Before Surgery)

• GAF Healthcare facilitates remote video consultation with the chosen plastic surgeon; 3D imaging files and medical records are reviewed electronically.
• Completion of mandatory diagnostics: mammography/ultrasound, blood panel, ECG, anaesthesia clearance.
• Caprini DVT risk score calculated; high-risk patients commence low-molecular-weight heparin (LMWH) perioperatively.
• Cessation of NSAIDs, aspirin, vitamin E, and herbal supplements ≥ 2 weeks prior (bleed risk).
• Smoking cessation confirmed ≥ 6 weeks preoperatively.
• Travel and accommodation arrangements finalised by GAF Healthcare; medical e-visa (India) or entry visa (UAE) processed.
• Arrival in country 1–2 days before surgery for in-person consultation, surgical marking, and pre-anaesthesia workup.

DAY OF Surgery